Science Leads the Charge in the Fight to Stop Parkinson’s Disease

Stopping Parkinson’s is a crucial need for millions of patients, and Vincere Biosciences is committed to winning this fight with a combination of Biology & Technology toward the development of new treatments that work through mechanisms that have never been tried before in the clinic.

Vincere’s approach to halting Parkinson’s is built upon three essential elements we focus on to maximize the probability of success.

Biology, Technology, and Finance – merging these three elements provides the foundation for Vincere Biosciences to work and develop Parkinson’s relief programs.

It is crucial that “Biology” is at the top – and our approach is always to follow the science.

Ultimately biology informs what is likely to work – and shows us how to find which patients are likely to benefit the most from each type of treatment.

Technologies and funding only help patients when they are fueling rigorous, patient-centric science.

Modern-age technology is improving at amazing rates, and by implementing the latest cutting-edge tools, we can more efficiently test hypotheses and accelerate development while minimizing resource consumption.

Each patient is different so the cause of disease or how a patient will respond to a therapeutic may be different. Computation gives us the power to examine very large amounts of data, terabytes, from each patient.

And there are new exciting technologies beyond computation. Some that drive our research include genetically engineered mice and cells that let us visualize biological processes in the living system – it’s like we’ve taken off the blindfolds!

Financial support is a key factor in this research since funding is required.

We’re grateful to our investors and organizations like the Michael J Fox Foundation and the National Institutes of Health for funding crucial research & development that puts us closer to a cure.

With a global disease like Parkinson’s and an even bigger impact with the shared mechanisms of aging, we are presented with an amazing opportunity to improve life and do well by doing good.

By bringing AI and financial modeling techniques into the fight to stop Parkinson’s, we can process trillions of data points and identify patterns in patient data that others might miss.

This way we can tease out some of the complexities of Parkinson’s Disease and develop medicines that stop it.

If you want to learn more about us and what we are doing to conquer age-related diseases.

← You can read more at vincerebio{com}.

Read the post on Linkedin: Click here